New strategies to combat HIV: augmenting antiviral immunity.
Smith
Kendall A
KA
Division of Immunology, New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, USA.
Boyle
Brain A
BA
D016915:AIDS Vaccines / Q000276:immunology / Q000627:therapeutic use*; D019380:Anti-HIV Agents / Q000276:immunology / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D024882:Drug Resistance, Viral / Q000276:immunology; D015488:HIV Antigens / Q000276:immunology; D015658:HIV Infections / Q000276:immunology* / Q000517:prevention & control* / Q000821:virology; D015497:HIV-1 / Q000187:drug effects* / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects / Q000276:immunology; D007114:Immunization / Q000379:methods*; D007376:Interleukin-2 / Q000276:immunology / Q000627:therapeutic use; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology; D012008:Recurrence
D016915:AIDS Vaccines; D019380:Anti-HIV Agents; D015488:HIV Antigens; D007376:Interleukin-2